

















Ever since the realization that aging is a regulated 
process, intense research has gone into uncovering the 
key players underlying its regulation. Among the most 
intriguing molecular factors that have been uncovered 
are the sirtuins, a family of NAD
+-dependent 
deacetylases that have been implicated in lifespan 
extension in model organisms ranging from yeast to 
flies[1]. Mammals contain seven members of the sirtuin 
family, SIRT1-7, of which SIRT1 has been the most 
extensively characterized. Although the exact role of 
sirtuins in mammalian aging awaits further elucidation, 
a barrage of recent studies have shown that the 
mitochondrial sirtuin SIRT3 has an important role to 
play in warding off the vicissitudes of aging. In the 
previous issue of Aging, Hafner et al. (2010) add to the 
growing body of evidence by showing that mice lacking 
SIRT3 develop severe age-related pathologies in the 
heart [2]. 
 
Aging in the heart is characterized by hypertrophy and 
fibrosis, although its exact causes are unknown. 
Employing SIRT3-/- mice, Hafner et al. present 
intriguing evidence linking these aging phenotypes to 
mitochondrial dysfunction and SIRT3[2].  The authors 
show that the hearts of SIRT3-/- mice are more prone to 
aging phenotypes and are less resistant to stress. They 
also note that the hearts of SIRT3-/- mice contain 
mitochondria that are significantly more susceptible to 
swelling, a hallmark of aging. The mitochondrial 
permeability transition pore (mPTP), a multi-protein 
complex, is thought to be one of the main culprits 
driving age-related pathology in mitochondria[3]. Thus, 
inhibition of the mPTP could potentially have major 
therapeutic value. The authors found that SIRT3 




















key component of the mPTP and a target of the 
prescription drug cyclosporine A (CsA) [4]. 
Interestingly, the lysine residue on CypD targeted by 
SIRT3 is adjacent to the CsA binding site, raising the 
possibility that deacetylation of CypD by SIRT3 might 
regulate its function. Whereas CsA also inhibits 
structurally-related cyclophilins, leading to suppression 
of the immune system, the findings of Hafner et al. open 
up the tantalizing possibility of targeting SIRT3 to 
specifically suppress the pernicious effects of CypD. 
 
This study combined with recent work by Someya et al. 
(2010), Kim et al. (2010), and Sundaresan et al. (2009) 
show that SIRT3 can delay the onset of age-related 
pathologies in multiple tissues [2, 5-7]. The present 
study also comes on the heels of studies by Qiu et al. 
(2010), Someya et al.  (2010), and Tao et al.  (2010) 
implicating SIRT3 in protection against oxidative stress, 
a major cause of age-related pathologies[6, 8, 9]. One of 
the targets uncovered, the mitochondrial antioxidant 
superoxide dismutase 2 (SOD2), has been linked to 
numerous longevity models.  Thus, a strong case has 
been built for SIRT3 as a protector against the ravages 
of aging. However, whether SIRT3 can actually extend 
lifespan is still unknown. Also, while SIRT3 activity is 
thought to decrease with age due to the lower levels of 
NAD
+, the aging phenotypes of SIRT3-/- mice are only 
apparent when the mice are older [2, 10]. It is still a 
mystery as to why SIRT3-/- mice are phenotypically 
normal when they are young. Much work remains to be 
done to further understand the role that SIRT3 plays in 
the aging process, but the floodgates have been opened, 
and SIRT3 is emerging as an increasingly attractive 
target for small molecule activators to extend 
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